The impact of TRT on other types of cancer, such as breast cancer or testicular cancer, is less well-studied. Patients with a history of hormone-sensitive cancers should consult their oncologists before considering TRT. The decision to proceed with TRT should be based on a comprehensive evaluation of the potential benefits and risks.